Welch & Forbes LLC Buys 8,461 Shares of Xylem Inc. $XYL

Welch & Forbes LLC boosted its stake in Xylem Inc. (NYSE:XYLFree Report) by 2.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 401,832 shares of the industrial products company’s stock after purchasing an additional 8,461 shares during the quarter. Welch & Forbes LLC owned about 0.17% of Xylem worth $54,722,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Fisher Asset Management LLC increased its holdings in shares of Xylem by 6.4% in the third quarter. Fisher Asset Management LLC now owns 404,613 shares of the industrial products company’s stock worth $59,681,000 after acquiring an additional 24,352 shares in the last quarter. LGT Capital Partners LTD. increased its holdings in shares of Xylem by 18.4% in the third quarter. LGT Capital Partners LTD. now owns 268,704 shares of the industrial products company’s stock worth $39,634,000 after acquiring an additional 41,730 shares in the last quarter. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Xylem by 2,309.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 431,824 shares of the industrial products company’s stock worth $54,314,000 after acquiring an additional 413,904 shares in the last quarter. ABN AMRO Bank N.V. increased its holdings in shares of Xylem by 2.3% in the third quarter. ABN AMRO Bank N.V. now owns 1,637,096 shares of the industrial products company’s stock worth $240,511,000 after acquiring an additional 36,992 shares in the last quarter. Finally, Abacus Wealth Partners LLC bought a new stake in shares of Xylem in the fourth quarter worth about $1,663,000. Institutional investors own 87.96% of the company’s stock.

Insider Activity

In other news, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the transaction, the chief accounting officer directly owned 3,605 shares of the company’s stock, valued at $423,443.30. This represents a 54.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jerome A. Peribere acquired 1,210 shares of Xylem stock in a transaction dated Monday, May 4th. The shares were purchased at an average cost of $116.61 per share, with a total value of $141,098.10. Following the completion of the transaction, the director directly owned 27,209 shares of the company’s stock, valued at $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.32% of the stock is owned by corporate insiders.

Xylem Stock Up 0.3%

XYL stock opened at $109.58 on Friday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.46 and a quick ratio of 1.10. The stock has a market capitalization of $26.05 billion, a P/E ratio of 27.26, a P/E/G ratio of 1.56 and a beta of 1.08. The business has a 50-day moving average of $117.84 and a 200-day moving average of $129.76. Xylem Inc. has a fifty-two week low of $105.29 and a fifty-two week high of $154.27.

Xylem (NYSE:XYLGet Free Report) last posted its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $1.09 by $0.03. The company had revenue of $2.13 billion during the quarter, compared to analysts’ expectations of $2.11 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.Xylem’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.03 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, sell-side analysts anticipate that Xylem Inc. will post 5.51 earnings per share for the current fiscal year.

Xylem declared that its Board of Directors has approved a stock repurchase plan on Wednesday, February 25th that authorizes the company to buyback $1.50 billion in shares. This buyback authorization authorizes the industrial products company to purchase up to 4.8% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s board believes its stock is undervalued.

Xylem Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th will be given a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 1.6%. The ex-dividend date of this dividend is Thursday, May 28th. Xylem’s dividend payout ratio is currently 42.79%.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on XYL. TD Cowen restated a “hold” rating on shares of Xylem in a report on Monday, February 23rd. Stifel Nicolaus lowered their price target on Xylem from $163.00 to $159.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. UBS Group increased their price target on Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. Royal Bank Of Canada lowered their price target on Xylem from $176.00 to $162.00 and set an “outperform” rating for the company in a report on Wednesday, February 11th. Finally, JPMorgan Chase & Co. lowered their price target on Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday, April 16th. Seven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, Xylem presently has an average rating of “Moderate Buy” and a consensus target price of $152.77.

Get Our Latest Report on XYL

Xylem Company Profile

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Read More

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.